Clinical Challenges: Use of Adjuvant Immunotherapy in RCC
More data awaited, but until then, decisions should be made on case-by-case basis
Source: medpagetoday.com
Page 8 - Adjuvant News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Adjuvant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Adjuvant Today - Breaking & Trending Today
Tumor DNA Assay Portends Metastatic Breast Cancer Recurrence Months in Advance
First evidence for patients in late adjuvant setting, years after initial diagnosis
Source: medpagetoday.com
F. Hoffmann-La Roche Ltd: European Commission approves Roche's Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resected Stage II-III NSCLC, compared with best supportive careTecentriq
Source: finanznachrichten.de
Roche's Tecentriq Gets EC Nod As Adjuvant Treatment For Certain People With Early-stage NSCLC
SOUTH SAN FRANCISCO (dpa-AFX) - Roche Holding AG's (RHHBY) blockbuster drug Tecentriq has been approved by the European Commission for yet another lung cancer indication - this time, as an adjuvant
Source: finanznachrichten.de
Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma
First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanomaA global partnership between EORTC and
Source: finanznachrichten.de